Sign up first!Yaoming Kangde Public Welfare Forum: Special Session of Muscle Atrophic Side Cable and neuromusculus Disease Theme

Edit

On June 25, when the "Frozen World Day" arrived, Yaoming Kant will host the "letting science lead" rare disease series of public welfare forums of the muscle atrophic sideline (ALS) and neuromuscular disease (NMD) Specialty, pay attention to the unsatisfactory medical needs in the ALS and NMD fields, analyze the challenges and opportunities of the current new drug research and development, and promote cooperation to bring transformators to patients.

The forum will bring more than 20 heavy guests in the world, top medical and research experts, patient organizations and patient representatives, new drug research and development big coffees, and will share their forward -looking insights on the development trend of ALS and NMD in multiple perspectives, and jointly explore the attack on the disease. The path of innovation.

The forum adopts the "invitation approval system", and does not charge any participation fee from 9: 00-11: 30 on June 25th, looking forward to meeting you online!

Guests and agenda

"Let science lead" Yaoming Kant Public Welfare Series Forum

Promoting change: Special session of muscle atrophy side sclerosis and neuromuscular disease

9: 00-11: 30 on June 25, Beijing time

9:00 Welcome to speech

Cai Hui, the chairman of the forum; vice president of Yaoming Kangde, the person in charge of the content department

Calaneet Balas, Chairman and CEO of ALS Association

9:10 Exploreless needs: The field of neuromuscular disease

Carsten Bönnemann, Director of Children's neuromusculus disease and neuropathic disease department of neuropathy and stroke of the Institute of Institute of Health in the United States

Matthew Harms, Associate Professor of Neuroscience in the Institute of Genomics, Columbia University

Guests of special hosts: Sharon Hesterlee, chief researcher at the Association of Somoscover

9:40 Focusing muscle atrophy side cable hardening

KULDIP DAVE, Vice President of ALS Association Senior Research

Sabrina Paganoni, co -director of the Institute of Neurology, Massachusetts General Hospital; clinical scientist Healey & AMG ALS Center

Jeffrey Rothstein, Director

10:10 on the research pipeline

Neil Cashman, Promis Neurosciences Chief Science Officer; Honorary Professor of British Columbia University

Michael McGrath, a professor of medical honor at the University of California San Francisco; the founder and chief science official of Neuvivo

Robert Scannevin, Verge Genomics Chief Scientific Officer

Fernando Vieira, CEO and Chief Science Officer of ALS Institute of Treatment Development

Hosting guests: MURALI Gopalakrishnan, Strategic Research and Evaluation of the Ministry of Strategy for Strategy

10:50 Challenges and opportunities for new molecular types

Jim Burns, CEO of Locanabio

Clive Svendsen, Professor and Executive Director of the Institute

Guests of special hosting: bibhash mukhopadhyay, sound bioventures management partner

11:20 The future direction of genes and individual chemical medical care

Michael SNYDER, professor and director of Stanford University of Genetics; Director of Genomics and Individual Chemical Medical Center

11:25 Outlook for the next ten years

Fan Dongsheng, director of neurology at the Third Hospital of Peking University, director

KULDIP DAVE, Vice President of ALS Association Senior Research

Cai Lei, ALS patient, corporate executive

Wang Jinhuan, Chairman of the Rare Disease Love Center of Beijing Oriental Silk Rain

Jeffrey Rothstein, Director

Lin Kah Ooi, the founding chairman of the Singapore Sports neurons Association

11:35 Closing speech

Richard SOLL, the head of Yaoming Kantonton Office and senior consultant of strategic planning

- END -